GLP-1RAs and opioid use disorder: a new frontier in addiction treatment
Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...
Many adults stop GLP-1 therapy within a year with low restart rates, analysis finds
A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...
ZME Science1d
Ozempic Blindness Could Be Rare but Real: What Experts Say About the Risk
Small studies link Ozempic and similar drugs to rare but serious eye conditions. However, experts say there's no need to ...
RIPR: The Public's Radio1d
When online weight-loss drugs are too good to be true
A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...
Zepbound for Weight Loss: What to Know About This Weight Loss Drug
For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...
Semaglutide Side Effects: Is It Safe? What You Need To Know
Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...
Knowridge4d
New diabetes drug helps lower blood sugar and lose weight faster
A recent study has found that the diabetes drug tirzepatide helps people with type 2 diabetes lower their blood sugar and ...
Scientists Explain ‘Ozempic Blindness,’ Link Between Sudden Vision Loss and Weight Loss Drugs
Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.
Medscape6d
Study Finds Websites Aren’t Always Transparent About Compounded GLP-1 RAs
A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic ...